The Prader-Willi Syndrome therapeutics market is anticipated to evolve immensely in the coming years, owing to the rise in the number of cases of Prader-Willi Syndrome and the expected launch of the pipeline therapies. The Prader-Willi Syndrome (PWS) pipeline possesses potential drugs in mid-and late-stage developments. Key players like Soleno Therapeutics, Levo Therapeutics, and others hold the potential to create a significant positive shift in the Prader-Willi Syndrome (PWS) market dynamics and treatment outlook.
“Prader-Willi Syndrome Pipeline Insight, 2023” report by DelveInsight outlines a comprehensive assessment of the present clinical/non-clinical development activities and growth prospects across the Prader-Willi Syndrome Market. The Prader-Willi Syndrome Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from pre-clinical developmental to marketed phases. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers, acquisition, funding, designations, and other product-related details. Prader-Willi Syndrome Pipeline Analysis The report provides insights into: The report provides detailed insights into the emerging therapies for the treatment of Prader-Willi Syndrome and the aggregate therapies developed by major pharma companies. It accesses the different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of clinical development. It outlines the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects. The report evaluates the drugs that are under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type. It navigates the major collaborations (company-company collaborations and company-academia collaborations), licensing agreements, financing details, data presentation by the pharma giants, and regulatory approval in the Prader-Willi Syndrome market. The report is built using data and information traced from the researcher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc. Analysis of Emerging Therapies by Phases The report covers the emerging products under different phases of clinical development like – Late-stage products (Phase III) Mid-stage products (Phase II) Early-stage product (Phase I) Pre-clinical and Discovery stage candidates Discontinued & Inactive candidates Route of Administration Prader-Willi Syndrome pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as Oral Parenteral Intravenous Subcutaneous Topical Molecule Type Products have been categorized under various Molecule types, such as Monoclonal Antibody Peptides Polymer Small molecule Gene therapy Mechanism of Action of the Emerging Pipeline Therapies Potassium channel agonists Iron chelating agents Serotonin uptake inhibitors Synaptic transmission modulators G protein-coupled receptor agonists Histamine H3 receptor inverse agonists Cannabinoid receptor modulators Ghrelin receptor antagonists Gastric inhibitory polypeptide receptor antagonists Learn How the Ongoing Clinical & Commercial Activities will Affect the Prader-Willi Syndrome Therapeutic Segment @ https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight Prader-Willi Syndrome Therapeutics Landscape Several major pharma and biotech companies are developing therapies for Prader-Willi Syndrome. Currently, Soleno Therapeutics is leading the therapeutics market with its Prader-Willi Syndrome drug candidates in the most advanced stage of clinical development. The Leading Companies in the Prader-Willi Syndrome Therapeutics Market Include: ConSynance Therapeutics GLWL Research Helsinn Inversago Pharma Larimar Therapeutics Levo Therapeutics LG Life Sciences Neuren Pharmaceuticals OptiNose Radius Health Rhythm Saniona Soleno Therapeutics Tonix Pharmaceuticals And Many Others Prader-Willi Syndrome Emerging and Marketed Drugs Covered in the Report Include: Diazoxide Choline Controlled-Release (DCCR): Soleno Therapeutics Inc. Intranasal carbetocin (LV-101): Levo Therapeutics GENOTROPIN (somatropin): Pfizer OMNITROPE: Sandoz And Many More Request the Sample PDF to Get a Better Understanding of the Emerging Drugs and Key Companies @ https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight Table of Content (TOC) 1. Report Introduction 2. Executive Summary 3. Prader-Willi Syndrome Current Treatment Patterns 4. Prader-Willi Syndrome – DelveInsight’s Analytical Perspective 5. Therapeutic Assessment 6. Prader-Willi Syndrome Late Stage Products (Phase-III) 7. Prader-Willi Syndrome Mid-Stage Products (Phase-II) 8. Prader-Willi Syndrome Early Stage Products (Phase-I) 9. Pre-clinical Products and Discovery Stage Products 10. Inactive Products 11. Dormant Products 12. Prader-Willi Syndrome Discontinued Products 13. Prader-Willi Syndrome Product Profiles 14. Key Companies in the Prader-Willi Syndrome Market 15. Key Products in the Prader-Willi Syndrome Therapeutics Segment 16. Dormant and Discontinued Products 17. Prader-Willi Syndrome Unmet Needs 18. Prader-Willi Syndrome Future Perspectives 19. Prader-Willi Syndrome Analyst Review 20. Appendix 21. Report Methodology *The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents. Download Sample PDF to Explore the Key Offerings of the Report @ https://www.delveinsight.com/sample-request/prader-willi-syndrome-pipeline-insight Connect with us and discover how Delveinsight can help you to identify your potential business partners and investors in the highly dynamic and evolving healthcare market today @ Healthcare Partner Identification Services About DelveInsight DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/